Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 14.09.2026 2 Brain 1 Curr Opin Immunol 1 Diabetes Res Clin Pract 4 Intern Med 2 J Autoimmun 1 J Nephrol 3 J Neuroimmunol 9 J Neurol 1 J Pediatr Endocrinol Metab 1 Kidney Int 1 Mult Scler 1 N Engl J Med 1 Nat Rev Neurol 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain

1. FAROOQ R, Cutler B, Pisa M, Balaram Kuttikkatte S, et al
   Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis.
   Brain. 2026 Sep 9:awag303. doi: 10.1093.
   PubMed         Abstract available
   
   
2. BROWN JWL
   Untangling prognosis in multiple sclerosis.
   Brain. 2026;149:2909-2911.
   PubMed        
   
   

   
   Curr Opin Immunol

3. ROSSANO M, Baldo F, Vaienna P, Lanni S, et al
   A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome.
   Curr Opin Immunol. 2026;103:102834.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

4. OKTAVIAN P, Kencono Wungu CD, Amin IM, Mudjanarko SW, et al
   Glycemic and safety outcomes of the insulin-only bionic pancreas in older adults and individuals with impaired awareness of Hypoglycemia: a post hoc analysis of a randomized pivotal trial.
   Diabetes Res Clin Pract. 2026;240:113542.
   PubMed         Abstract available
   
   

   
   Intern Med

5. TOKUNAGA Y, Azuma K, Irie K, Watanabe M, et al
   Guillain-Barre Syndrome Following the Administration of Tarlatamab in Extensive-stage Small Cell Lung Cancer: A Case Report with Pathological Confirmation.
   Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.7771.
   PubMed         Abstract available
   
   
6. NAKAMURA J, Hagiwara Y, Furukawa Y, Matsukura K, et al
   Posterior Cortical Atrophy Phenocopy Associated with Antiphospholipid Syndrome: A Case Report.
   Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.7598.
   PubMed         Abstract available
   
   
7. YAMAMOTO M, Dembo T, Sawada K, Yoshida Y, et al
   A Diagnostic Approach to Giant Cell Arteritis Initially Presenting with Infarction without Headache Using MR Vessel Wall Imaging and a Temporal Artery Biopsy: A Case Report.
   Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.7447.
   PubMed         Abstract available
   
   
8. KANEKO M, Yamawaki M, Murayama M, Furuya J, et al
   A Survival Case of Pulmonary Hemorrhage Caused by Disseminated Strongyloidiasis in Systemic Lupus Erythematosus.
   Intern Med. 2026 Sep 8. doi: 10.2169/internalmedicine.7424.
   PubMed         Abstract available
   
   

   
   J Autoimmun

9. IORIO L, Davanzo F, Lorenzoni G, Gasparini D, et al
   Rheumatoid factor is associated with systemic relapse in eosinophilic granulomatosis with polyangiitis.
   J Autoimmun. 2026;163:103613.
   PubMed         Abstract available
   
   
10. LARSEN ML, Demir F, Langkilde HZ, Linge P, et al
    Disease-activity-linked complement-coagulation interactions and persistent platelet activation in treatment-naive systemic lupus erythematosus.
    J Autoimmun. 2026;164:103615.
    PubMed         Abstract available
    
    

    
    J Nephrol

11. HUANG Z, Ma J, Bian X
    Clinical Significance of Increased Degree of Hematuria in Patients affected by IgA Nephropathy.
    J Nephrol. 2026 Sep 7:aajag241. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

12. JIN Y, Seo D, Yun H, Jang IH, et al
    Chronic pain despite lower lesion burden in double-seronegative longitudinally extensive transverse myelitis.
    J Neuroimmunol. 2026;420:579032.
    PubMed         Abstract available
    
    
13. ERICHSEN PA, Heerfordt IM, Framke E, Magyari M, et al
    Dipeptidyl peptidase-4 inhibitors and risk of multiple sclerosis: A Danish nationwide matched case-control study.
    J Neuroimmunol. 2026;421:579097.
    PubMed         Abstract available
    
    
14. WILBUR C, Zhu F, Zhao Y, Tremlett H, et al
    Disease-modifying therapy uptake in a pediatric-onset multiple sclerosis population, British Columbia, Canada.
    J Neuroimmunol. 2026;421:579083.
    PubMed         Abstract available
    
    

    
    J Neurol

15. LINDROOS JLV, Gilhus NE, Brauner S, Bjork MH, et al
    Medication use trajectories in myasthenia gravis pregnancies: a population-based drug utilization study.
    J Neurol. 2026;273:572.
    PubMed         Abstract available
    
    
16. HEBER ME, Li Y, Raymond DP, Li Y, et al
    A comparison study of thymectomy outcomes in young and older patients with non-thymomatous myasthenia gravis.
    J Neurol. 2026;273:566.
    PubMed         Abstract available
    
    
17. MIESENBERGER AS, Arlt FA, Koschutzke L, Gebert P, et al
    Autoantibodies targeting G protein-coupled receptors and clinical outcome after ischemic stroke (PROSCIS-B).
    J Neurol. 2026;273:581.
    PubMed         Abstract available
    
    
18. MARINO V, Moiola L, Zanetta C, Rubin M, et al
    Ocrelizumab versus ofatumumab efficacy and safety after natalizumab discontinuation in multiple sclerosis: a retrospective real-world comparison.
    J Neurol. 2026;273:577.
    PubMed        
    
    
19. MULLER T, Giles L, Hauquiert B, Gonze A, et al
    Severe invasive pneumococcal pneumonia following influenza A in a patient with multiple sclerosis treated with dimethyl fumarate: the importance of vaccination assessment and hematologic monitoring.
    J Neurol. 2026;273:571.
    PubMed        
    
    
20. GUO J, Wu J, Olsson T, Alfredsson L, et al
    Genetic modification of obesity-associated disability progression in multiple sclerosis.
    J Neurol. 2026;273:578.
    PubMed         Abstract available
    
    
21. ESPOSITO A, Corsaro L, Cave ID, Capasso F, et al
    Ofatumumab in multiple sclerosis: 2-year immune profiling and clinical correlates.
    J Neurol. 2026;273:579.
    PubMed         Abstract available
    
    
22. MATTIESING RM, Gentile G, Battaglini M, De Stefano N, et al
    The predictive value of serum neurofilament light chain levels beyond MRI measures for clinical and radiological disease progression in the earliest stages of multiple sclerosis.
    J Neurol. 2026;273:584.
    PubMed         Abstract available
    
    
23. MORI Y, Takekoshi A, Ono Y, Yoshikura N, et al
    Characteristics and prognostic factors of cognitive impairment in autoimmune glial fibrillary acidic protein astrocytopathy.
    J Neurol. 2026;273:586.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

24. VELASQUEZ HJ, Huang X, Minard C, Siller AF, et al
    Overweight and obesity in youth with type 1 diabetes.
    J Pediatr Endocrinol Metab. 2026;39:866-874.
    PubMed         Abstract available
    
    

    
    Kidney Int

25. KAVANAGH D, Alladin-Karan A, Alexander S, Chauvet S, et al
    Outcomes from the International Society of Nephrology forum on complement therapeutics in C3 glomerulopathy and IgA nephropathy.
    Kidney Int. 2026 Aug 26:S0085-2538(26)00711-8. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available
    
    

    
    Mult Scler

26. GIOVANNETTI AM, Pakenham KI, Copetti M, Brichetto G, et al
    A group resilience training program for people with multiple sclerosis: A cluster-randomized controlled trial (multi-READY for MS).
    Mult Scler. 2026 Sep 7:13524585261464886. doi: 10.1177/13524585261464886.
    PubMed         Abstract available
    
    

    
    N Engl J Med

27. SOLER MJ
    A Step Forward - Obinutuzumab for Membranous Nephropathy.
    N Engl J Med. 2026;395:1024-1026.
    PubMed        
    
    

    
    Nat Rev Neurol

28. CALABRESE M, Magliozzi R, Tamanti A, Ziccardi S, et al
    Cortical lesions in multiple sclerosis: 25 years of progress, remaining challenges and future directions.
    Nat Rev Neurol. 2026 Sep 7. doi: 10.1038/s41582-026-01263.
    PubMed         Abstract available
    
    

    
    PLoS One

29. WESTER TREJO MAC, Kuijper TM, Waverijn GJ, Bajema IM, et al
    ANCA testing strategies: A single centre experience over the past decade in a large teaching hospital in the Netherlands.
    PLoS One. 2026;21:e0357495.
    PubMed         Abstract available
    
    
30. BERRY SA, Iqbal A, Elliott J, Gandhi R, et al
    Pain alleviation in diabetic neuropathy using hybrid closed loop insulin pumps (PAINLESS) - A randomised crossover trial protocol.
    PLoS One. 2026;21:e0357573.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

31. NANOU A, Apostolou-Karampelis K, Triantafyllidou V, Sakkou M, et al
    Fibronectin inhibition restores myelination in endothelial TNFR2-dependent nonremitting experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 2026;123:e2616799123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum